UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2856-2864

2004

Link zum Volltext

Verfügbarkeit prüfen

7LBA Safety, activity, and response durability assessment of single agent rovalpituzumab tesirine, a delta-like protein 3 (DLL3)-targeted antibody drug conjugate (ADC), in small cell lung cancer (SCLC)

European journal of cancer (1990), 2015-09, Vol.51, p.S712-S712

2015

Link zum Volltext

Verfügbarkeit prüfen

IMRT for Organ Preservation in Hypopharynx Cancer Provides Good Locoregional Control

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S534-S535

2014

Link zum Volltext

Verfügbarkeit prüfen

Gastrostomy Tube Rates Decrease by Over 50% in Patients With Nasopharyngeal Cancer Treated With Intensity Modulated Proton Therapy (IMPT): A Case–Control Study

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S528-S528

2014

Link zum Volltext

Verfügbarkeit prüfen

IMRT for Oropharyngeal Carcinoma: Patient Outcomes and Patterns of Failure

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S15-S16

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Concurrent and Adjuvant Chemotherapy with Intensity Modulated Radiation Therapy (IMRT) or Three-dimensional Conformal Radiotherapy (3D-CRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer (NPC)[RTOG 0615]: Preliminary Toxicity Report

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S103-S104

2010

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Disease Recurrence following Radiation for Oropharyngeal Cancer

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S32-S32

2009

Link zum Volltext

Verfügbarkeit prüfen

Outcomes following Proton Therapy for Squamous Cell Carcinoma of the Larynx

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1213-1213

2020

Link zum Volltext

Verfügbarkeit prüfen

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

Annals of oncology, 2019-03, Vol.30 (3), p.471-477

2019

Link zum Volltext

Verfügbarkeit prüfen

Results of Radiation Therapy Oncology Group 97-03—A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck: Long-term Results and Late Toxicities

International journal of radiation oncology, biology, physics, 2007, Vol.69 (2), p.S140-S140

2007

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Update of a Phase II Study of Concurrent Chemoradiotherapy Using Radiation + Bevacizumab (BV) For Locally or Regionally Advanced Nasopharyngeal Cancer (NPC): RTOG 0615

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1119-1119

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of neoadjuvant cemiplimab prior to surgery in patients with stage III/IV (M0) cutaneous squamous cell carcinoma of the head and neck (CSCC-HN)

Annals of oncology, 2019-10, Vol.30, p.v910

2019

Link zum Volltext

Verfügbarkeit prüfen

LBA74 - Phase II study of neoadjuvant cemiplimab prior to surgery in patients with stage III/IV (M0) cutaneous squamous cell carcinoma of the head and neck (CSCC-HN)

Annals of oncology, 2019-10, Vol.30, p.v910-v910

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors

Annals of oncology, 2016-10, Vol.27, p.vi361-vi361

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of MK-3475 and Concurrent Radiation for the Elimination of Extensive-Stage Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.S18-S18

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of MK-3475 and Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e727-e727

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Study of Pembrolizumab and Stereotactic or Hypofractionated Radiation for Metastatic Non–small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S160-S161

2017

Link zum Volltext

Verfügbarkeit prüfen

Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2000-02, Vol.18 (3), p.609-622

2000

Link zum Volltext

Verfügbarkeit prüfen

2362

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S411

2006

Link zum Volltext

Verfügbarkeit prüfen

2362: Results of Radiation Therapy Oncology Group 97–03 - A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck: Long Term Results and Late Toxicities

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S411-S411

2006

Link zum Volltext

Verfügbarkeit prüfen

P2.90. A phase II trial of ZD 1839 (Gefitinib) for advanced cutaneous squamous cell carcinoma of head and neck

Oral oncology. Supplement, 2009-07, Vol.3 (1), p.190-190

2009

Link zum Volltext

Verfügbarkeit prüfen

Sinonasal carcinoma with neuroendocrine differentiation: patterns of failure according to histologic phenotype

International journal of radiation oncology, biology, physics, 2003-10, Vol.57 (2), p.S248-S249

2003

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with gemcitabine plus cisplatin (CDDP): a phase I trial for patients with stage III non-small cell lung cancer (NSCLC)

European journal of cancer (1990), 2001-04, Vol.37, p.S53-S54

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase III trial of amifostine with chemoradiation for inoperable non-small cell lung cancer (NSCLC): does amifostine protect cancer cells

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.105-105

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of farnesyl tranferase inhibitors (FTI) SCH66336 with paclitaxel in solid tumors: Dose finding, pharmacokinetics, efficacy/safety

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.63-64

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(1)

Erscheinungsjahr

n.n

Kollektion

Ingenta
(28)
Elsevier ScienceDirect Journals Complete
(25)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(24)
IngentaConnect Journals
(9)
EZB Electronic Journals Library
(6)
Journals@Ovid
(6)
MEDLINE
(3)
Publisher or Other Site
(2)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

International Journal Of Radiation Oncology, Biology, Physics
(15)
Lung Cancer
(7)
Annals Of Oncology
(4)
European Journal Of Cancer
(2)
Journal Of Clinical Oncology
(2)
Oral Oncology. Supplement
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck

7LBA Safety, activity, and response durability assessment of single agent rovalpituzumab tesirine, a delta-like protein 3 (DLL3)-targeted antibody drug conjugate (ADC), in small cell lung cancer (SCLC)

IMRT for Organ Preservation in Hypopharynx Cancer Provides Good Locoregional Control

Gastrostomy Tube Rates Decrease by Over 50% in Patients With Nasopharyngeal Cancer Treated With Intensity Modulated Proton Therapy (IMPT): A Case–Control Study

IMRT for Oropharyngeal Carcinoma: Patient Outcomes and Patterns of Failure

Phase II Study of Concurrent and Adjuvant Chemotherapy with Intensity Modulated Radiation Therapy (IMRT) or Three-dimensional Conformal Radiotherapy (3D-CRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer (NPC)[RTOG 0615]: Preliminary Toxicity Report

Patterns of Disease Recurrence following Radiation for Oropharyngeal Cancer

Outcomes following Proton Therapy for Squamous Cell Carcinoma of the Larynx

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

Results of Radiation Therapy Oncology Group 97-03—A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck: Long-term Results and Late Toxicities

Long-Term Update of a Phase II Study of Concurrent Chemoradiotherapy Using Radiation + Bevacizumab (BV) For Locally or Regionally Advanced Nasopharyngeal Cancer (NPC): RTOG 0615

Phase II study of neoadjuvant cemiplimab prior to surgery in patients with stage III/IV (M0) cutaneous squamous cell carcinoma of the head and neck (CSCC-HN)

LBA74 - Phase II study of neoadjuvant cemiplimab prior to surgery in patients with stage III/IV (M0) cutaneous squamous cell carcinoma of the head and neck (CSCC-HN)

Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors

Phase I Trial of MK-3475 and Concurrent Radiation for the Elimination of Extensive-Stage Small Cell Lung Cancer

Phase I Trial of MK-3475 and Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer

Phase 1 Study of Pembrolizumab and Stereotactic or Hypofractionated Radiation for Metastatic Non–small Cell Lung Cancer

Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung Cancer

2362

2362: Results of Radiation Therapy Oncology Group 97–03 - A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck: Long Term Results and Late Toxicities

P2.90. A phase II trial of ZD 1839 (Gefitinib) for advanced cutaneous squamous cell carcinoma of head and neck

Sinonasal carcinoma with neuroendocrine differentiation: patterns of failure according to histologic phenotype

Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with gemcitabine plus cisplatin (CDDP): a phase I trial for patients with stage III non-small cell lung cancer (NSCLC)

Phase III trial of amifostine with chemoradiation for inoperable non-small cell lung cancer (NSCLC): does amifostine protect cancer cells

Phase I study of farnesyl tranferase inhibitors (FTI) SCH66336 with paclitaxel in solid tumors: Dose finding, pharmacokinetics, efficacy/safety

Suchergebnisse filtern